vs
VINCE HOLDING CORP.（VNCE）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是VINCE HOLDING CORP.的1.5倍（$127.1M vs $85.1M），再鼎医药同比增速更快（17.1% vs 6.2%），VINCE HOLDING CORP.自由现金流更多（$-5.7M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 6.3%）
Vince是创立于2002年的现代时装品牌，主打简约高级的日常服饰，深受都市消费者喜爱。2023年，Authentic Brands Group以7650万美元收购了该品牌的知识产权。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
VNCE vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.5倍
$85.1M
营收增速更快
ZLAB
高出10.9%
6.2%
自由现金流更多
VNCE
多$21.0M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
6.3%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $85.1M | $127.1M |
| 净利润 | $2.7M | — |
| 毛利率 | 49.2% | 51.0% |
| 营业利润率 | 6.4% | -54.6% |
| 净利率 | 3.2% | — |
| 营收同比 | 6.2% | 17.1% |
| 净利润同比 | -37.3% | — |
| 每股收益（稀释后） | $0.21 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收VNCEZLAB
| Q4 25 | $85.1M | $127.1M | ||
| Q3 25 | $73.2M | $115.4M | ||
| Q2 25 | $57.9M | $109.1M | ||
| Q1 25 | $80.0M | $105.7M | ||
| Q4 24 | $80.2M | $108.5M | ||
| Q3 24 | $74.2M | $101.8M | ||
| Q2 24 | $59.2M | $100.1M | ||
| Q1 24 | $75.3M | $87.1M |
净利润VNCEZLAB
| Q4 25 | $2.7M | — | ||
| Q3 25 | $12.1M | $-36.0M | ||
| Q2 25 | $-4.8M | $-40.7M | ||
| Q1 25 | $-28.3M | $-48.4M | ||
| Q4 24 | $4.3M | — | ||
| Q3 24 | $569.0K | $-41.7M | ||
| Q2 24 | $4.4M | $-80.3M | ||
| Q1 24 | $-4.7M | $-53.5M |
毛利率VNCEZLAB
| Q4 25 | 49.2% | 51.0% | ||
| Q3 25 | 50.4% | 59.5% | ||
| Q2 25 | 50.3% | 60.6% | ||
| Q1 25 | 50.1% | 63.6% | ||
| Q4 24 | 50.0% | 61.5% | ||
| Q3 24 | 47.4% | 64.1% | ||
| Q2 24 | 50.6% | 64.9% | ||
| Q1 24 | 45.4% | 61.4% |
营业利润率VNCEZLAB
| Q4 25 | 6.4% | -54.6% | ||
| Q3 25 | 15.2% | -42.3% | ||
| Q2 25 | -7.7% | -50.3% | ||
| Q1 25 | -37.1% | -53.3% | ||
| Q4 24 | 7.2% | -62.6% | ||
| Q3 24 | 1.5% | -66.6% | ||
| Q2 24 | 9.5% | -76.0% | ||
| Q1 24 | -2.2% | -80.7% |
净利率VNCEZLAB
| Q4 25 | 3.2% | — | ||
| Q3 25 | 16.5% | -31.2% | ||
| Q2 25 | -8.3% | -37.3% | ||
| Q1 25 | -35.5% | -45.8% | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | 0.8% | -40.9% | ||
| Q2 24 | 7.4% | -80.2% | ||
| Q1 24 | -6.2% | -61.4% |
每股收益（稀释后）VNCEZLAB
| Q4 25 | $0.21 | $-0.05 | ||
| Q3 25 | $0.93 | $-0.03 | ||
| Q2 25 | $-0.37 | $-0.04 | ||
| Q1 25 | $-2.25 | $-0.04 | ||
| Q4 24 | $0.34 | $-0.09 | ||
| Q3 24 | $0.05 | $-0.04 | ||
| Q2 24 | $0.35 | $-0.08 | ||
| Q1 24 | $-0.37 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $53.4M | $715.5M |
| 总资产 | $246.0M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资VNCEZLAB
| Q4 25 | $1.1M | $689.6M | ||
| Q3 25 | $777.0K | $717.2M | ||
| Q2 25 | $2.6M | $732.2M | ||
| Q1 25 | $607.0K | $757.3M | ||
| Q4 24 | $892.0K | $779.7M | ||
| Q3 24 | $711.0K | $616.1M | ||
| Q2 24 | $739.0K | $630.0M | ||
| Q1 24 | $357.0K | $650.8M |
股东权益VNCEZLAB
| Q4 25 | $53.4M | $715.5M | ||
| Q3 25 | $49.3M | $759.9M | ||
| Q2 25 | $37.2M | $791.7M | ||
| Q1 25 | $41.8M | $810.8M | ||
| Q4 24 | $57.1M | $840.9M | ||
| Q3 24 | $52.4M | $667.7M | ||
| Q2 24 | $51.7M | $704.2M | ||
| Q1 24 | $47.2M | $762.2M |
总资产VNCEZLAB
| Q4 25 | $246.0M | $1.2B | ||
| Q3 25 | $239.0M | $1.2B | ||
| Q2 25 | $218.0M | $1.2B | ||
| Q1 25 | $222.7M | $1.2B | ||
| Q4 24 | $254.7M | $1.2B | ||
| Q3 24 | $253.6M | $985.3M | ||
| Q2 24 | $223.1M | $987.4M | ||
| Q1 24 | $225.1M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.1M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $-5.7M | $-26.7M |
| 自由现金流率自由现金流/营收 | -6.7% | -21.0% |
| 资本支出强度资本支出/营收 | 0.7% | 0.5% |
| 现金转化率经营现金流/净利润 | -1.86× | — |
| 过去12个月自由现金流最近4个季度 | $4.3M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流VNCEZLAB
| Q4 25 | $-5.1M | $-26.0M | ||
| Q3 25 | $4.2M | $-32.0M | ||
| Q2 25 | $-11.8M | $-31.0M | ||
| Q1 25 | $22.7M | $-61.7M | ||
| Q4 24 | $6.4M | $-55.8M | ||
| Q3 24 | $-3.2M | $-26.8M | ||
| Q2 24 | $-3.9M | $-42.2M | ||
| Q1 24 | $14.8M | $-90.1M |
自由现金流VNCEZLAB
| Q4 25 | $-5.7M | $-26.7M | ||
| Q3 25 | $2.1M | $-35.0M | ||
| Q2 25 | $-13.2M | $-33.9M | ||
| Q1 25 | $21.2M | $-63.2M | ||
| Q4 24 | $5.1M | $-58.4M | ||
| Q3 24 | $-3.9M | $-28.2M | ||
| Q2 24 | $-4.6M | $-42.9M | ||
| Q1 24 | $14.2M | $-91.1M |
自由现金流率VNCEZLAB
| Q4 25 | -6.7% | -21.0% | ||
| Q3 25 | 2.9% | -30.4% | ||
| Q2 25 | -22.9% | -31.1% | ||
| Q1 25 | 26.5% | -59.9% | ||
| Q4 24 | 6.4% | -53.8% | ||
| Q3 24 | -5.2% | -27.7% | ||
| Q2 24 | -7.8% | -42.9% | ||
| Q1 24 | 18.9% | -104.5% |
资本支出强度VNCEZLAB
| Q4 25 | 0.7% | 0.5% | ||
| Q3 25 | 2.9% | 2.6% | ||
| Q2 25 | 2.5% | 2.6% | ||
| Q1 25 | 1.9% | 1.5% | ||
| Q4 24 | 1.6% | 2.4% | ||
| Q3 24 | 0.9% | 1.3% | ||
| Q2 24 | 1.3% | 0.7% | ||
| Q1 24 | 0.7% | 1.1% |
现金转化率VNCEZLAB
| Q4 25 | -1.86× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.48× | — | ||
| Q3 24 | -5.61× | — | ||
| Q2 24 | -0.89× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
VNCE
| Vince Wholesale | $52.0M | 61% |
| Vince Direct To Consumer | $33.1M | 39% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
